5,6-Dimethoxybenzofuran-3-one derivatives: A novel series of dual Acetylcholinesterase/Butyrylcholinesterase inhibitors bearing benzyl pyridinium moiety

DARU, Journal of Pharmaceutical Sciences

Volumn 21, Issue 1, 2013, Pages

  Nadri, Hamid ^a   Pirali Hamedani, Morteza ^b   Moradi, Alireza ^a   Sakhteman, Amirhossein ^a   Vahidi, Alireza ^a   Sheibani, Vahid ^c   Asadipour, Ali ^c   Hosseinzadeh, Nouraddin ^d   Abdollahi, Mohammad ^b   Shafiee, Abbas ^b   Foroumadi, Alireza ^c,d  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 FLUOROBENZYL) 4 ((5,6 DIMETHOXY 3 OXOBENZOFURAN 2 (3H)YLIDENE)METHYL)PYRIDINIUM CHLORIDE; 1 (2 METHYLBENZYL) 4 ((5,6 DIMETHOXY 3 OXOBENZOFURAN 2(3H)YLIDENE)METHYL)PYRIDINIUM CHLORIDE; 1 (3 FLUOROBENZYL) 4 ((5,6 DIMETHOXY 3 OXOBENZOFURAN 2(3H)YLIDENE)METHYL)PYRIDINIUM CHLORIDE; 1 (3 METHYLBENZYL) 4 ((5,6 DIMETHOXY 3 OXOBENZOFURAN 2 (3H)YLIDENE)METHYL)PYRIDINIUM CHLORIDE; 1 (4 FLUOROBENZYL) 4 ((5,6 DIMETHOXY 3 OXOBENZOFURAN 2 (3H)YLIDENE)METHYL)PYRIDINIUM BROMIDE; 1 (4 METHYLBENZYL) 4 ((5,6 DIMETHOXY 3 OXOBENZOFURAN 2 (3H)YLIDENE)METHYL)PYRIDINIUM CHLORIDE; 1 BENZYL 4 ((5,6 DIMETHOXY 3 OXOBENZOFURAN 2(3H)YLIDENE)METHYL)PYRIDINIUM BROMIDE; 2 CHLORO 1 (2 HYDROXY 4,5 DIMETHOXYPHENYL)ETHANONE; 3,4 DIMETHOXYPHENOL; 5,5' DITHIOBIS(2 NITROBENZOIC ACID); 5,6 DIMETHOXY 2 (PYRIDIN 4 YLMETHYLENE)BENZOFURAN 3(2H)ONE; 5,6 DIMETHOXYBENZOFURAN 3(2H)ONE; BENZOFURAN DERIVATIVE; CHOLINESTERASE INHIBITOR; DONEPEZIL; HYDROCHLORIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL REACTION; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME ACTIVITY; MOLECULAR DOCKING;

EID: 84874854518     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-21-15     Document Type: Article

References (23)

1. Novel stilbenes as probes for amyloid plaques. Kung HF, Lee CW, Zhuang ZP, Kung MP, Hou C, Plossl K, J Am Chem Soc 2001 123 12740 12741 10.1021/ja0167147 11741464 (Pubitemid 33140424)
2. Clinical features of Alzheimer's disease. Forstl H, Kurz A, Eur Arch Psychiatry Clin Neurosci 1999 249 288 290 10.1007/s004060050101 10653284 (Pubitemid 30011730)
3. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties. Fernandez-Bachiller MI, Perez C, Campillo NE, Paez JA, Gonzalez-Munoz GC, Usan P, Garcia-Palomero E, Lopez MG, Villarroya M, Garcia AG, Martinez A, Rodriguez-Franco MI, ChemMedChem 2009 4 828 841 10.1002/cmdc.200800414 19308922
4. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL, Science 1989 245 417 420 10.1126/science.2474201 2474201 (Pubitemid 19203368)
5. Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K, Proc Natl Acad Sci U S A 1985 82 4245 4249 10.1073/pnas.82.12.4245 3159021 (Pubitemid 15053619)
6. The cholinergic hypothesis of geriatric memory dysfunction. Bartus RT, Dean RL III, Beer B, Lippa AS, Science 1982 217 408 414 10.1126/science.7046051 7046051
7. Treatment of autoimmune myasthenia gravis. Richman DP, Agius MA, Neurology 2003 61 1652 1661 10.1212/01.WNL.0000098887.24618.A0 14694025 (Pubitemid 38020807)
8. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review. Repantis D, Laisney O, Heuser I, Pharmacol Res 2010 61 473 481 10.1016/j.phrs.2010.02.009 20193764
9. The exploration of thienothiazines as selective butyrylcholinesterase inhibitors. Karlsson D, Fallarero A, Brunhofer G, Mayer C, Prakash O, Mohan CG, Vuorela P, Erker T, Eur J Pharm Sci 2012 47 190 205 10.1016/j.ejps.2012.05.014 22683890
10. Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. Musial A, Bajda M, Malawska B, Curr Med Chem 2007 14 2654 2679 10.2174/092986707782023217 17979717 (Pubitemid 350048322)
11. Design, synthesis and anticholinesterase activity of a novel series of 1-benzyl-4-((6-alkoxy-3-oxobenzofuran-2(3H)-ylidene) methyl) pyridinium derivatives. Nadri H, Pirali-Hamedani M, Shekarchi M, Abdollahi M, Sheibani V, Amanlou M, Shafiee A, Foroumadi A, Bioorg Med Chem 2010 18 6360 6366 10.1016/j.bmc.2010.07.012 20673725
12. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors. Sheng R, Lin X, Zhang J, Chol KS, Huang W, Yang B, He Q, Hu Y, Bioorg Med Chem 2009 17 6692 6698 10.1016/j.bmc.2009.07.072 19692250
13. Design, synthesis and AChE inhibitory activity of indanone and aurone derivatives. Sheng R, Xu Y, Hu C, Zhang J, Lin X, Li J, Yang B, He Q, Hu Y, Eur J Med Chem 2009 44 7 17 10.1016/j.ejmech.2008.03.003 18436348
14. A new and rapid colorimetric determination of acetylcholinesterase activity. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM, Biochem Pharmacol 1961 7 88 95 10.1016/0006-2952(61)90145-9 13726518
15. Total synthesis of wedelolactone. Li CC, Xie ZX, Zhang YD, Chen JH, Yang Z, J Org Chem 2003 68 8500 8504 10.1021/jo030228f 14575477 (Pubitemid 37329110)
16. Search for dual function inhibitors for Alzheimer's disease: synthesis and biological activity of acetylcholinesterase inhibitors of pyridinium-type and their Abeta fibril formation inhibition capacity. Kapkova P, Alptuzun V, Frey P, Erciyas E, Holzgrabe U, Bioorg Med Chem 2006 14 472 478 10.1016/j.bmc.2005.08.034 16198581 (Pubitemid 41767607)
17. Synthesis and biological activity of pyridinium-type acetylcholinesterase inhibitors. Alptuzun V, Kapkova P, Baumann K, Erciyas E, Holzgrabe U, J Pharm Pharmacol 2003 55 1397 1404 10.1211/0022357021855 14607022 (Pubitemid 37321383)
18. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Trott O, Olson AJ, J Comput Chem 2010 31 455 461 19499576
19. Python: a programming language for software integration and development. Sanner MF, J Mol Graph Model 1999 17 57 61 10660911 (Pubitemid 30029318)
20. Open Babel: an open chemical toolbox. O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR, J Cheminform 2011 3 33 10.1186/1758-2946-3-33 21982300
21. UCSF Chimera-a visualization system for exploratory research and analysis. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE, J Comput Chem 2004 25 1605 1612 10.1002/jcc.20084 15264254
22. Functionalized aurones as inducers of NAD(P)H:quinone oxidoreductase 1 that activate AhR/XRE and Nrf2/ARE signaling pathways: synthesis, evaluation and SAR. Lee CY, Chew EH, Go ML, Eur J Med Chem 2010 45 2957 2971 10.1016/j.ejmech.2010.03.023 20392544
23. Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds. Sugimoto H, Iimura Y, Yamanishi Y, Yamatsu K, J Med Chem 1995 38 4821 4829 10.1021/jm00024a009 7490731